Document Detail


Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?
MedLine Citation:
PMID:  18963203     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Increased cardiovascular risk in diabetes cannot be attributed to the higher prevalence of classic risk factors.
IMPORTANCE OF POSTPRANDIAL HYPERGLYCEMIA: Most of the cardiovascular risk factors have shown to be directly related to the degree of postprandial glycemia (PPG). PPG should be recognized as a marker for the increased risk of cardiovascular disease.
ASSESSMENT OF TARGETS FOR GLYCEMIA CONTROL: Two important methods available-self-monitoring of blood glucose (SMBG) reveals immediate hour-to-hour blood glucose, while long-term glycemia is assessed by HbA1c. Reducing PPG and glycemia excursions is as important as lowering fasting plasma glucose and HbA1c levels.
EFFECTIVENESS OF SMBG: SMBG plays a key role in diabetes care, and has proven to be effective for insulin treated type 2 diabetic patients. Debate continues on the effectiveness of SMBG in non-insulin treated type 2 diabetes. Whether non-insulin treated type 2 diabetic patients benefit from SMBG, a large-scale randomized controlled trial with the follow-up period to investigate long-term effects should be carried out. A general recommendation is that insulin treated patients perform SMBG at least three times per day. SMBG frequency for non-insulin users should be individualized to treatment regimen and level of control.
Authors:
Egle Varanauskiene
Related Documents :
21270263 - Hyperglycemia activates caspase-1 and txnip-mediated il-1beta transcription in human ad...
16112963 - Quality control of smbg in clinical practice.
23199543 - Ace inhibitors or arbs for diabetic nephropathy: the unrelenting debate.
Publication Detail:
Type:  Journal Article; Review     Date:  2008-10-29
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  82 Suppl 2     ISSN:  1872-8227     ISO Abbreviation:  Diabetes Res. Clin. Pract.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-08     Completed Date:  2009-04-20     Revised Date:  2013-07-15    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  S112-7     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, Kaunas Medical University Hospital, Kaunas University of Medicine, Eiveniu 2, Kaunas LT-50009, Lithuania. evaranauskiene@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Glucose Self-Monitoring*
Diabetes Mellitus, Type 2 / blood*,  metabolism
Humans
Hyperglycemia / diagnosis,  prevention & control

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Homogeneity of solids: A proposal for quantitative definition.
Next Document:  Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene...